Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin.
Kaori NakataniKenji MomoTakashi MimuraEri YoshiizumiTadanori SasakiPublished in: Clinical case reports (2022)
In this report, we present a 37-year-old woman with villous cancer who developed AKI after co-administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.